TWI629267B - 二胺基吩噻鎓化合物之純化方法 - Google Patents

二胺基吩噻鎓化合物之純化方法 Download PDF

Info

Publication number
TWI629267B
TWI629267B TW103128051A TW103128051A TWI629267B TW I629267 B TWI629267 B TW I629267B TW 103128051 A TW103128051 A TW 103128051A TW 103128051 A TW103128051 A TW 103128051A TW I629267 B TWI629267 B TW I629267B
Authority
TW
Taiwan
Prior art keywords
methylene blue
complex
onium
item
acid
Prior art date
Application number
TW103128051A
Other languages
English (en)
Chinese (zh)
Other versions
TW201527287A (zh
Inventor
馬維恩 尹提克
Original Assignee
益友製藥私人有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903099A external-priority patent/AU2013903099A0/en
Application filed by 益友製藥私人有限公司 filed Critical 益友製藥私人有限公司
Publication of TW201527287A publication Critical patent/TW201527287A/zh
Application granted granted Critical
Publication of TWI629267B publication Critical patent/TWI629267B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
TW103128051A 2013-08-15 2014-08-15 二胺基吩噻鎓化合物之純化方法 TWI629267B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013903099A AU2013903099A0 (en) 2013-08-15 Purification method and compounds
??2013903099 2013-08-15

Publications (2)

Publication Number Publication Date
TW201527287A TW201527287A (zh) 2015-07-16
TWI629267B true TWI629267B (zh) 2018-07-11

Family

ID=52467850

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103128051A TWI629267B (zh) 2013-08-15 2014-08-15 二胺基吩噻鎓化合物之純化方法

Country Status (14)

Country Link
US (1) US9701648B2 (cg-RX-API-DMAC7.html)
EP (1) EP3033331B1 (cg-RX-API-DMAC7.html)
JP (1) JP6111381B2 (cg-RX-API-DMAC7.html)
KR (1) KR101741235B1 (cg-RX-API-DMAC7.html)
CN (1) CN105612148B (cg-RX-API-DMAC7.html)
BR (1) BR112016002979A8 (cg-RX-API-DMAC7.html)
CA (1) CA2920505C (cg-RX-API-DMAC7.html)
DK (1) DK3033331T3 (cg-RX-API-DMAC7.html)
IL (1) IL243937A (cg-RX-API-DMAC7.html)
MX (1) MX354492B (cg-RX-API-DMAC7.html)
NZ (1) NZ630569A (cg-RX-API-DMAC7.html)
SG (1) SG11201601003PA (cg-RX-API-DMAC7.html)
TW (1) TWI629267B (cg-RX-API-DMAC7.html)
WO (1) WO2015021500A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3375777A1 (en) * 2017-03-15 2018-09-19 MIKROCHEM spol. s.r.o. Method for preparation of 3,7-bis-(dimethylamino)-phenothiazin-5-ium chloride or bromide
CN112358475B (zh) * 2020-11-30 2022-09-06 西北师范大学 一种苯并吡喃鎓-吩噻嗪衍生物及其制备方法和应用
CN116947783B (zh) * 2022-04-19 2026-04-17 英科隆生物技术(杭州)有限公司 一种电子媒介体的提纯方法
US20250270177A1 (en) * 2022-04-19 2025-08-28 Leadway (Hk) Limited Purification method for electron mediator

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293757A (en) * 1968-10-22 1972-10-25 Paines & Byrne Ltd A nerve stain composition
US20090291943A1 (en) * 2006-07-12 2009-11-26 Michel Feraud Process for preparing diaminophenothiazinium compounds
JP2009542786A (ja) * 2006-07-11 2009-12-03 ウイスタ・ラボラトリーズ・リミテッド ジアミノフェノチアジニウム化合物の合成および/または精製の方法
WO2012107706A1 (en) * 2011-02-11 2012-08-16 Wista Laboratories Ltd. Phenothiazine diaminium salts and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909520A (en) 1959-10-20 Process for making acylated
DE1886C (de) 1877-12-15 1877-12-15 Basf Ag Verfahren zur darstellung blauer farbstoffe aus dimethylanilin und anderen tertiaeren aromatischen monaminen
GB0327672D0 (en) * 2003-11-28 2003-12-31 Photopharmica Ltd Developments in biologically active methylene blue derivatives (phenothiazines)
BRPI0416928A (pt) * 2003-11-28 2007-01-16 Photopharmica Ltd desenvolvimento de derivados biologicamente ativos de azul de metileno
JP5186212B2 (ja) * 2004-09-23 2013-04-17 ウィスタ ラボラトリーズ リミテッド メチルチオニニウム塩化物(mtc)などのジアミノフェノチアジニウム化合物を化学合成および精製する方法
WO2006032879A2 (en) 2004-09-23 2006-03-30 Wista Laboratories Ltd. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293757A (en) * 1968-10-22 1972-10-25 Paines & Byrne Ltd A nerve stain composition
JP2009542786A (ja) * 2006-07-11 2009-12-03 ウイスタ・ラボラトリーズ・リミテッド ジアミノフェノチアジニウム化合物の合成および/または精製の方法
US20090291943A1 (en) * 2006-07-12 2009-11-26 Michel Feraud Process for preparing diaminophenothiazinium compounds
WO2012107706A1 (en) * 2011-02-11 2012-08-16 Wista Laboratories Ltd. Phenothiazine diaminium salts and their use

Also Published As

Publication number Publication date
WO2015021500A1 (en) 2015-02-19
SG11201601003PA (en) 2016-03-30
EP3033331A4 (en) 2017-01-18
KR101741235B1 (ko) 2017-05-29
CA2920505C (en) 2018-04-03
DK3033331T3 (da) 2018-04-30
CA2920505A1 (en) 2015-02-19
IL243937A0 (en) 2016-04-21
EP3033331A1 (en) 2016-06-22
EP3033331B1 (en) 2018-02-21
IL243937A (en) 2017-01-31
CN105612148A (zh) 2016-05-25
US20160200696A1 (en) 2016-07-14
MX2016002085A (es) 2016-06-23
MX354492B (es) 2018-03-07
BR112016002979A8 (pt) 2020-02-04
JP2016528237A (ja) 2016-09-15
AU2014306354A1 (en) 2016-02-18
US9701648B2 (en) 2017-07-11
KR20160042929A (ko) 2016-04-20
TW201527287A (zh) 2015-07-16
CN105612148B (zh) 2018-09-14
JP6111381B2 (ja) 2017-04-05
NZ630569A (en) 2017-06-30

Similar Documents

Publication Publication Date Title
JP5934404B2 (ja) ジアミノフェノチアジニウム化合物の調製方法
CN102702205A (zh) 西他列汀的制备方法
CN105612148B (zh) 用于纯化二氨基吩噻嗪化合物的方法
RU2019130882A (ru) Способ получения хлорида или бромида 3,7-бис-(диметиламино)-фенотиазин-5-ия
CN107226794A (zh) 一种法匹拉韦的合成方法
CN114085225A (zh) 一种伐地那非类似物及其合成方法和应用
CN109438374B (zh) 卢非酰胺的连续化合成方法
JP2021195344A (ja) 5−ブロモ−2−ハロゲン化安息香酸の製造方法
AU2014306354B2 (en) Process for the purification of diaminophenothiazinium compounds
US10160735B2 (en) Process for the purification of diaminophenothiazinium compounds
CN111320547A (zh) 一种苯芴醇-d9的合成方法
HK1225026A1 (en) Process for the purification of diaminophenothiazinium compounds
CN107721874B (zh) 一种采用微流场反应技术制备硝酸酯类化合物的方法
CN119823064B (zh) 一种亚甲蓝的制备方法
CN106008195B (zh) 一种2,4-二氟-5-碘苯甲酸的制备方法
JP6275596B2 (ja) テルミサルタンのアンモニウム塩の製造方法
CN118908834A (zh) 一种4-甲基-3-硝基苯甲酸乙酯的制备方法
CN118908835A (zh) 一种2-硝基-5-氟苯甲醚的制备方法
CN107955008A (zh) 一种吡唑并嘧啶类化合物的合成方法
WO2025245928A1 (zh) 一种10,11-二溴-5H-二苯并[b,f]氮杂䓬-5-甲酰氯的化学合成方法
CN118908875A (zh) 一种1-甲基-2-硝基-3-(1,4-萘醌-2-基)吲哚及其制备方法
CN116947592A (zh) 一种2,7-二氯芴衍生物的制备方法
CN119462557A (zh) 一种多替诺雷关键中间体的制备方法
JP3257371B2 (ja) 5−フタルイミド−4−オキソペンテン酸またはそのピリジン塩の製造方法
CN117447351A (zh) 一种利多卡因的制备方法

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees